Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - fludarabine phosphate - pdr for soln inj/inf - 50 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - fludarabine phosphate - concentrate for soln for inf - 25 micromol

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - fludarabine phosphate - lyophilisate for solution for injection - 50 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - fludarabine phosphate, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; purified talc; titanium dioxide; iron oxide yellow; iron oxide red - indicated for use as second-line tharapy in patients with chronic lymphocytic leukaemia (cll). indications as at 6 april 2004: for the treatment of b-cell chronic lymphocytic leukaemia.

United States - English - NLM (National Library of Medicine)

accord healthcare, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) -

Malta - English - Malta Medicines Authority

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents

Malta - English - Malta Medicines Authority

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - film-coated tablet - fludarabine phosphate 10 mg - antineoplastic agents

Israel - English - Ministry of Health

novartis israel ltd - fludarabine phosphate - concentrate for solution for injection / infusion - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk ltd - fludarabine phosphate - pdr for soln inj/inf - 50 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - fludarabine phosphate - pdr for soln inj/inf - 50 milligram